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bstract
The micronization of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) from organic solutions using supercritical antisolvent (SAS)
echnique has been successfully achieved.
SAS experiments were carried out at different operational conditions and microspheres with mean diameters ranging from 3 to 9m were obtained.
he effect of CO2 and liquid flow, temperature and pressure on particle size and particle size distribution was evaluated. The microspheres were
recipitated from a dichloromethane (DCM) solution. The best process conditions for this mixture were, according to our study, 40 ◦C, 100 bar,
mL min−1 liquid flow and 10 L min−1 carbon dioxide flow.
Experiments with polymers containing different HV percentages were carried out. The powders obtained became more spherical as the HV
ontent decreased.
2006 Elsevier B.V. All rights reserved.
Drug
o
P
r
w
(
p
d
u
b
B
d
c
b
t
s
neywords: Supercritical fluids; Micronization; SAS; Natural polymers; PHBV;
. Introduction
The use of biocompatible and biodegradable polymers as
rug-carrier systems is increasing continuously in pharmaceuti-
al applications, since they can successfully deliver the drug to
target side that reduces the side effects and enhance the ther-
peutic benefit (Shariati and Peters, 2003). Several controlled
rug delivery systems are available and can be used however the
se of micro and nanoparticles appears to be the most interesting
ay as these systems facilitate the diffusion through biological
arriers. For such systems, size and morphology of the polymer
atrix assumes an extremely important role in the drug release
nd pharmacokinetics. Although several polymers have been
sed in the pharmaceutical industry, polyhydroxyalkanoates
PHAs), a biodegradable thermoplastic polymer produced by
enewable resources, have gained extensive interest as drug
arrier due to its singular properties (Pouton and Akhtar,
996; Chen and Wu, 2005). The most common type of PHAs
s poly(3-hydroxybutyrate) (PHB). PHB exhibits properties
imilar to polypropylene (PP) such as melting point, degree
∗ Corresponding author. Fax: +351 21 446 11 61.
E-mail address: cduarte@itqb.unl.pt (A.R.C. Duarte).
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f cristallinity and glass transition temperature. However
HB is stiffer and more brittle than PP, which can restrict its
ange of applications. On the other hand, PHB copolymers
ith 3-hydroxyvalerate (PHBV) are less stiff and tougher
Gunaratne and Shanks, 2005; Ray and Bousmina, 2005). The
roperties of this copolymer depend on the HV content, which
etermines the polymer crystallinity (Peng et al., 2003). The
se of PHBV had a tremendous increase in applications in the
iomedical field, in the past few years (Sendil et al., 1999;
aran et al., 2002; Chen and Davis, 2002; Chen and Wu, 2005),
ue to the fact that it is possible to prepare an appropriate
ontrolled drug delivery system that gradually degrades in the
ody.
Production of micro or nanoparticles using supercritical fluid
echnology is very attractive since it provides an alternative
olution to the various problems encountered in traditional tech-
iques (Yeo and Kiran, 2005). The possibility of producing very
mall particles with a narrow size distribution using mild and
nert conditions represents a major improvement over the con-
entional processes (Elvassore et al., 2003).One of the available particle formation technique based
n supercritical fluids is the supercritical antisolvent process,
eferred as SAS, ASES, PCA, or SEDS in literature (Foster et al.,
003; Yeo and Kiran, 2005) depending on the process arrange-
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ents and apparatus. Nevertheless, the principle inherent to all
hese processes is the same, i.e., to decrease the solvent power
f the liquid by addition of an antisolvent in which the solute is
nsoluble. The selection of a proper combination of the organic
olvent and the antisolvent for a particular polymer is essential
or the success of the process. The organic solvent should have
reasonable miscibility towards the polymer and also a high
olubility in the supercritical fluid under moderate operating
onditions. This method of particle formation is based on two
echanisms that take place simultaneously, on one hand, the
uid penetrates into the droplets where it acts as an antisolvent
or the dissolved material and on the other hand the organic
olvent evaporates on the supercritical fluid so that precipitation
ccurs (Mukhopadhyay and Dalvi, 2004). Since the diffusivity
f the supercritical fluid is higher than the diffusivity of a liquid,
he diffusion of the fluid into the organic solvent produces a
aster supersaturation of the solute solved in the liquid and
herefore its precipitation into micronized particles.
The low solubility of polymers in carbon dioxide and their
elatively high solubility in organic solvents provide suitable
onditions to preferably employ this process for particle forma-
ion and design of improved controlled delivery systems.
Process variables, such as temperature, pressure and flow
ate, have a strong influence in the morphology of the parti-
les, as well as their particle size and particle size distribution.
hese variables directly interfere with the basic mechanisms
hat control particle formation, which are fluid dynamics, mass
ransfer, nucleation kinetics and thermodynamics (Reverchon et
l., 2003).
Bleich et al. (1993) report the use of supercritical fluids,
amely the ASES technique to process PHB. The aim of this
ork is to provide a better understanding of the process vari-
bles, such as concentration of liquid solution, pressure, tem-
erature, liquid and carbon dioxide flow, in the precipitation of
HBV, in order to optimise the process conditions. The effect
f the HV content on the copolymer was also evaluated.
. Experimental procedure
.1. Materials
Poly(3-hydroxybutyrate), PHB (CAS 26063-00-3), poly(3-
ydroxybutyrate-co-3-hydroxyvalerate), PHBV, with 8% and
2% HV (CAS 80181-31-3) and poly[(R)-3-hydroxybutyric
cid-co-(R)-3-hydroxyvaleric acid], PHBV, with 30% HV (CAS
2267-82-8), were purchased from Sigma, Aldrich and Fluka.
ichloromethane, DCM (CAS 78-09-2, 99.9% purity) and chlo-
oform (CAS 67-66-3, 99.0% purity) were purchased from
anreac. Carbon dioxide (99.998 mol%) was supplied by Air
iquide. All chemicals were used with no further purification.
.2. Microsphere preparationThe precipitation experiments were carried out in a SAS
pparatus, which has been described elsewhere (Duarte et al.,
006). The apparatus works in a continuous co-current mode
nd it consists of a precipitator in which the antisolvent and
2
c
ef Pharmaceutics 328 (2007) 72–77 73
he liquid solution are separately fed to the top of the chamber
nd are continuously discharged from the bottom. The liquid
olution is pumped into the chamber by a high pressure piston
ump (Knauer HPLC pump K-501). The antisolvent is deliv-
red by means of a high pressure piston pump (Haskel model
CPV-71).
The precipitator is a cylindrical vessel with an inner volume
f 500 cm3. The liquid solution is delivered into the chamber
hrough a stainless steel nozzle. The carbon dioxide is heated,
p to the temperature of the experiment, before entering the
recipitator in a tube section by an electric cable (CS 12854),
hich is connected to a temperature controller (Ero Electronic
MS-491-13).
The precipitator is heated by means of two electric thin
ands heater (Watlow STB3J2J1) also connected to a temper-
ture controller. The pressure in the chamber is measured by a
ressure gauge manometer (Bourdon–Haenni models MVX7 D
0 B38). The outflow is regulated by a micrometric valve (Hoke
315G4Y) located at the bottom of the precipitator. This valve
s heated with an electric cable (CS 12854) in order to prevent
he freezing of carbon dioxide due to the rapid depressurisation
50 ◦C). A filter of sintered steel with 0.1m porosity is placed
t the bottom of the vessel to collect the particles produced.
The solvents are separated and recovered from a second
essel. Usually the temperature of the vessel is around 15 ◦C
nd pressure 5–10 bar. The pressure in the separator is mea-
ured by a pressure gauge manometer (Bourdon–Haenni model
VX7 D30 B29) and regulated by a back pressure valve (Tescon
urope).
The carbon dioxide flow rate and the total quantity of anti-
olvent used are measured by a flow meter (Aalborg GFM
7S-VADL2-E).
.3. Particle characterization
.3.1. Scanning electron microscopy—SEM
Samples of the precipitated powder were observed by a
EISS 960 scanning electron microscope (SEM). The particles
ere fixed by mutual conductive adhesive tape on aluminium
tubs and covered with gold palladium using a sputter coater.
.3.2. Particle size and size distribution
The particle size and size distribution of the prepared
icroparticles were measured by Laser diffraction spectrom-
try (Coulter LS 130, Coulter Electronics). The dried powder
amples were suspended in deionised water with a surfactant
olution (Coulter Dispersant, Coulter) and sonicated for 1 min
ith an ultra-sound probe (500 W, Vibra Cell, Sonics & Mate-
ials, Inc.) before measurement. The obtained homogeneous
uspension was determined for the volume mean diameter, size
istribution and polydispersity. Each sample was analysed three
imes..3.3. Differential scanning calorimetry
Differential scanning calorimetry (DSC) measurements were
arried out on a Setaram DSC 131 scanning calorimeter
quipped with a thermal analysis data system Samples of 10 mg
74 M.S. Costa et al. / International Journal of Pharmaceutics 328 (2007) 72–77
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1Fig. 1. PHBV micronized from (
ere placed in aluminum pans and sealed The probes were
eated from 20 to 250 ◦C at a rate of 10 ◦C/min under nitro-
en atmosphere.
. Results and discussion
In this study, the possibility of micronization of biocompat-
ble and biodegradable polymers such PHB and PHBV using
upercritical fluid technology is evaluated. The selection of a
roper organic solvent is essential for the success of the process
ince the miscibility of the liquid solvent in supercritical CO2
lays a key role in this technique. Therefore, volumetric expan-
ion curves have to be considered before starting the experiments
or a given solvent. The best organic solvents for these poly-
ers are chloroform and dichloromethane (Pouton and Akhtar,
996). The operational conditions for the first experiments were
hosen considering the volumetric expansion curves (Scurto et
l., 2001; Vega-Gonza´lez et al., 2002), and taken into account
he fact that the presence of a single phase favours the process.
herefore, a preliminary experiment using a solution of chloro-
orm and a solution of dichloromethane were performed at 100
nd 80 bar, respectively and 40 ◦C. This experiment was done
n order to evaluate which solvent is the best one for the anti-
olvent micronization process. Particles, precipitated from both
olutions using CO2 as an anti-solvent, present similar mor-
hology as it can be seen on Fig. 1. Furthermore, the particles
s
t
t
able 1
ummary of the experiments performed
xperiment System P (bar) T (◦C) C0 (mg mL−1)
1 PHBV 12% 80 40 25
2 PHBV 12% 80 40 12.5
3 PHBV 12% 80 35 12.5
4 PHBV 12% 80 45 12.5
5 PHBV 12% 80 40 12.5
6 PHBV 12% 80 40 12.5
7 PHBV 12% 80 40 12.5
8 PHBV 12% 90 40 12.5
9 PHBV 12% 100 40 12.5
0 PHBV 8% 80 40 12.5
1 PHBV 30% 80 40 12.5
2 PHB 100 40 12.5oroform and (b) dicloromethane.
f PHBV precipitated from organic solutions through a 300m
ozzle exhibit identical narrow size distribution with a mean par-
icle size of 5.8 and 5.3m for dichloromethane and chloroform,
espectively.
Despite the similarity of results using these two solvents,
he selected organic solvent to precipitate PHBV using SAS
echnique was DCM due to its lower toxicity, and also because
higher yield was achieved when using this solvent.
The experiments were designed in order to determine the best
perational conditions for the production of PHBV microparti-
les. In each set of experiments one of the variables was modified
o that, the effect of the different variables on the morphology,
article size and particle size distribution could be evaluated.
he experiments performed are summarized in Table 1.
The effect of the polymer concentration in the liquid solu-
ion on the particle size was evaluated. From the results of the
EM analysis (Fig. 2) it is possible to conclude that a lower
oncentration favours the precipitation of particles with smaller
ize diameter. The SEM analysis demonstrated that agglomer-
ted particles were obtained when a higher concentration was
sed for the precipitation process (Fig. 2b). Therefore, all other
xperiments were carried out with a low concentration solution.The influence of the temperature was the second parameter
tudied. Three experiments show that an isobaric increase in
emperature from 35 to 40 ◦C causes a decrease in the mean par-
icle size from 7.0 to 5.9m. Experiments performed at higher
Liquid flow (mL min−1) CO2 flow (L min−1) MSD (m)
0.75 10 –
0.75 10 5.9
0.75 10 7.0
0.75 10 –
1.00 7.5 5.8
1.00 10 5.9
1.00 12.5 8.3
1.00 10 6.9
1.00 10 6.1
1.00 10 7.0
1.00 10 6.2
1.00 10 5.9
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Fig. 2. Effect of concentration of the liquid soluti
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pig. 3. Particle size distribution of PHBV micronized from a liquid solution
ow of 0.75 mL min−1 (*) and 1 mL min−1 (–).
emperatures, produced a polymeric film in the bottom of the ves-
el. So, the optimal temperature for the precipitation of PHBV
icroparticles is 40 ◦C.
Experiments with different liquid solution and carbon dioxide
ows were performed. The liquid flow does not seem to affect the
article size. Nevertheless, the particle size distribution is nar-
ower when particles were precipitated from a liquid solution
ow of 1 mL min−1 (Fig. 3). The CO2 flow varied from 7.5 to
2.5 L min−1. As it can be seen from Fig. 4, an increase in carbon
ioxide flow increases the particle size. Although there are no
ignificant differences, regarding particle size and particle size
istribution from experiments performed at 7.5 and 10 L min−1,
Fig. 4. Effect of CO2 flow rate on the mean particle size.
a
p
fon (a) 12.5 mg mL−1 and (b) 25 mg mL−1.
he higher carbon dioxide flow was chosen to continue the exper-
ments. This promotes a better mixing between the solvents and
igher turbulence near the jet point, which favours the precipita-
ion process. Therefore, from the results obtained, 1 mL min−1
iquid flow and 10 L min−1 CO2 flow were chosen to continue
he study.
The last variable evaluated in the precipitation process was
he pressure. A pressure increase from 80 to 90 bar caused a sig-
ificant decrease in the particle size, however a further increase
n pressure did not significantly influenced the diameter of the
articles (Fig. 5). Reverchon (Reverchon, 1999) found that for
ressures larger than the asymptotic volume expansion there is
o significant effect of the pressure in the particle size and par-
icle size distribution of the powders precipitated.
With the results obtained, it is possible to conclude that for
his system the best operating conditions are 40 ◦C, 100 bar,
mL min−1 liquid flow and 10 L min−1 carbon dioxide flow.
Furthermore, the specific surface area was analyzed. As
xpected the surface area decreases with increasing particle
ize (Fig. 6). Small errors might derive from the presence of
gglomerates that were not completely dispersed in the sample
reparation.Differential scanning calorimetry was performed in order to
nalyse the differences between the processed and unprocessed
olymer, nevertheless no major conclusions can be withdrawn
rom this analysis as there is a splitting of the fusion peak.
Fig. 5. Effect of pressure on the mean size diameter.
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Fig. 6. Specific surface area vs. particle size.
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cig. 7. Diferential scanning calorimetry (DSC) of PHBV 8% (1) processed
experiment 10) (2) unprocessed.
ig. 7 presents the DSC for PHBV 8% processed at 40 ◦C, 80 bar
experiment 10) and also the unprocessed PHBV 8%. The use
f ultra-sounds to enhance the solubility of PHBV in the organic
olvent might promote the break down of the polymeric chains,
onsequently the sample will present a broader molecular weight
istribution than the initial sample. The heterogeneity of the
s
t
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s
Fig. 8. SEM images of (a) PHBV 30%; (b)ig. 9. Particle size distribution of PHBV 30% (©); PHBV 12% (–); PHBV 8%
); PHB ().
esulting sample causes the splitting of the peak and therefore
o substantial conclusions can be taken.
Experiments with polymers containing different HV percent-
ges were also carried out. Fig. 8 presents the SEM images of
he particles prepared from different polymer blends, confirming
he success of the experiments.
There is an obvious difference in the morphology of the par-
icles precipitated with 30% HV and the others. This difference
s not so evident when the HV content decreases from 12 or 8%.
n these cases the particles obtained become more spherical. The
ifference in the particle size distribution of the PHB particles
Fig. 9) precipitated might be due to the fact that this experiment
as carried out with a different solvent and different operational
onditions. The PHB had to be precipitated from a chloroform
olution because it was impossible to dissolve this polymer in
he same concentration using dichloromethane. For this reason,
he precipitating conditions were slightly different, i.e., the pres-
ure was 100 bar instead of 80 bar. This ensured the presence of
PHBV 12%; (c) PHBV 8%; (d) PHB.
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Sig. 10. Mean particle size of powder precipitated from different PHBV blends.
single phase in the precipitation chamber. In Fig. 10, the mean
article size of the different polymers is plotted as a function of
he HV content.
. Conclusions
PHBV microspheres were successfully precipitated from
n organic solution using the supercritical antisolvent process
SAS). Operational conditions that affect the particle size and
article size distribution, such as liquid and carbon dioxide flow,
ressure and temperature, were evaluated in order to optimise
he process and smaller particles were obtained at 40 ◦C and
0 bar with 1 mL min−1 liquid flow and 10 L min−1 CO2 flow
ate.
Experiments with polymers with different HV content were
lso carried out. The powders obtained become more spherical
s the HV content decreases.
cknowledgments
Mariana Sousa Costa and Ana Rita C. Duarte are grate-
ul for financial support from SFRH/BD/17224/2004 and
FRH/BD/10780/2002 grants, respectively. This work was
nancially supported by FCT-MCES, Portugal, under con-
ract POCTI/EQU/46715/2002 from the QCA III/FEDER. The
uthors would like to acknowledge the Analytical Services Lab-
ratory of REQUIMTE for the DSC results and to Prof. Ana
amos for the transfer of knowledge related with the interpre-
ation of DSC plots.
V
Yf Pharmaceutics 328 (2007) 72–77 77
eferences
aran, E.T., ¨Ozer, N., Hasirci, V., 2002. Poly(hydroxybutirate-co-
hydroxyvalerate) nanocapsules as enzyme carriers for cancer therapy: an in
vitro study. J. Microencapsul. 19, 363–376.
leich, J., Mu¨ller, B.W., Wassmus, W., 1993. Aerosol solvent extraction
system—a new microparticulate production technique. Int. J. Pharm. 97,
111–117.
hen, G.Q., Wu, Q., 2005. The application of polyhydroxyalcanoates as tissue
engineering materials. Biomaterials 26, 6565–6578.
hen, J., Davis, S.S., 2002. The release of diazepam from poly(hydroxybutyrate-
hydroxyvalerate) microspheres. J. Microencapsul. 19, 191–201.
uarte, A.R.C., Gordillo, M., Cardoso, M.M., Simplı´cio, A.L., Duarte, C.M.M.,
2006. Preparation of ethylcellulose/methylcellulose blends by supercritical
antisolvent precipitation. Int. J. Pharm. 311, 50–54.
lvassore, N., Parton, T., Bertucco, A., Di Noto, V., 2003. Kinetics of particle
formation in the gas antisolvent precipitation process. AIChE J. 49, 859–868.
oster, N., Mammucari, R., Dehghani, F., Barrett, A., Bezanehtak, K., Coen, E.,
Combes, G., Meure, L., Ng, A., Regtop, H.L., Tandya, A., 2003. Processing
pharmaceutical compounds using dense gas technology. Ind. Eng. Chem.
Res. 42, 6476–6493.
unaratne, L.M.W.K., Shanks, R.A., 2005. Multiple melting behaviour of
poly(3-hydroxybutyrate-co-hydroxyvalerate) using step scan DSC. Eur.
Polym. J. 41, 2980–2988.
ukhopadhyay, M., Dalvi, S.V., 2004. Mass and heat transfer analysis of SAS:
effects of thermodynamic states and flow rates on droplet size. J. Supercrit.
Fluids 30, 333–348.
eng, S., An, Y., Chen, C., Fei, B., Zhuang, Y., Dong, L., 2003. Isothermal
crystallization of poly(3-hydroxybutyrate-co-hydroxyvalerate). Eur. Polym.
J. 39, 1475–1480.
outon, C.W., Akhtar, S., 1996. Biosynthetic polyhydroxyalcanoates and their
application in drug delivery. Adv. Drug Deliv. Rev. 18, 133–162.
ay, S.S., Bousmina, M., 2005. Biodegradable polymers and their layered sil-
icate nanocomposites: in greening the 21st century materials world. Prog.
Mater. Sci. 50, 962–1079.
everchon, E., 1999. Supercritical antisolvent precipitation of micro- and nano-
particles. J. Supercrit. Fluids 15, 1–21.
everchon, E., Caputo, G., De Marco, I., 2003. Role of phase behavior and
atomization in the supercritical antisolvent precipitation. Ind. Eng. Chem.
Res. 42, 6406–6414.
curto, A.M., Lubbers, C.M., Xu, G., Brennecke, J.F., 2001. Experimental
measurement and modelling of the vapour–liquid equilibrium of carbon
dioxide + chloroform. Fluid Phase Equilib. 190, 135–147.
endil, D., Gu¨rsel, I., Wise, D.L., Hisirci, V., 1999. Antibiotic release from
biodegradable PHBV microparticles. J. Control. Rel. 59, 207–217.
hariati, A., Peters, C.J., 2003. Recent developments in particle design using
supercritical fluids. Curr. Opin. Solid State Mater. Sci. 7, 371–383.ega-Gonza´lez, A., Tufeu, R., Subra, P., 2002. High-pressure vapor–liquid equi-
librium for the binary systems carbon dioxide + dimethyl sulfoxide and
carbon dioxide + dichloromethane. J. Chem. Eng. Data 47, 492–495.
eo, S.D., Kiran, E., 2005. Formation of polymer particles with supercritical
fluids: a review. J. Supercrit. Fluids 34, 287–308.
